Lower dexamethasone dose does not impair survival in multiple myeloma

by

For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not negatively impact survival, according to a study published online Jan. 2 in Blood.

Leave A Comment

Your email address will not be published. Required fields are marked *